An M8 Greyhound of the 16th Armored Division rolls through the main square in Pilsen, Czech Republic during the liberation on ...

名为LIBERATE-1的试验正在澳大利亚进行，标志着Vivani专有NanoPortal™药物植入技术的首次应用。该试验旨在评估exenatide植入剂在超重或肥胖参与者中的安全性、耐受性和药代动力学特征，以体重变化作为主要衡量指标。

According to the report, battlegroup Center made Ukraine suffer roughly 610 casualties and lose two tanks in the Donetsk People’s Republic ...

The NHRC says those compelling Wole Soyinka and Femi Falana to lead a protest against economic hardship lack a sense of ...

Defense Minister Yaşar Güler says they have faith in Syrian National Army (SNA) to liberate territories occupied by the ...

By Greg McQuade Click here for updates on this story RICHMOND, Virginia (WTVR) — As a journalist for WTVR, I’ve shared the stories of people all across Central Virginia. But for this assignment, I ...

Writing for GPonline as the government unveiled an £889m general practice funding boost, primary care minister Stephen ...

Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP ...

加利福尼亚州阿拉米达 - 市值7167万美元的生物制药公司Vivani Medical, Inc. (NASDAQ: VANI)已开始其GLP-1(艾塞那肽)植入物的首次人体临床试验,这是治疗肥胖症的一项重大进展。这项名为LIBERATE-1的试验正在澳大利亚进行,标志着该公司专有NanoPortal™药物植入技术的首次临床应用。根据InvestingPro的数据,该股今年以来已上涨超过18%,尽 ...

Vivani Medical began the LIBERATE-1 trial, testing a six-month exenatide implant for chronic weight management in Australia. The study uses NanoPortal technology, with results expected in mid-2025 and ...

Major Shivdev Singh Sidhu and Captain Vijay Sehgal, both hailing from Ludhiana district, lost their lives during Operation ...